Immutep Ltd
ASX:IMM
Intrinsic Value
The intrinsic value of one
IMM
stock under the Base Case scenario is
1.837
AUD.
Compared to the current market price of 0.265 AUD,
Immutep Ltd
is
Undervalued by 86%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Immutep Ltd.
Fundamental Analysis
Delays or failures in Immutep’s lead product candidate eftilagimod alpha could undermine its pipeline credibility, especially given the high stakes of LAG-3–targeted therapies and the company’s limited clinical-stage assets.
Eftilagimod alpha’s encouraging clinical data in combination with checkpoint inhibitors suggests a strong potential to become a new standard in immuno-oncology, particularly for challenging cancers like metastatic breast cancer.
Revenue & Expenses Breakdown
Immutep Ltd
Balance Sheet Decomposition
Immutep Ltd
| Current Assets | 149.1m |
| Cash & Short-Term Investments | 129.7m |
| Receivables | 10.9m |
| Other Current Assets | 8.5m |
| Non-Current Assets | 7.9m |
| PP&E | 569.5k |
| Intangibles | 7.2m |
| Other Non-Current Assets | 116.5k |
Free Cash Flow Analysis
Immutep Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Immutep Ltd
|
Revenue
|
60.1k
AUD
|
|
Operating Expenses
|
-70.2m
AUD
|
|
Operating Income
|
-70.1m
AUD
|
|
Other Expenses
|
8.7m
AUD
|
|
Net Income
|
-61.4m
AUD
|
IMM Profitability Score
Profitability Due Diligence
Immutep Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
Score
Immutep Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
IMM Solvency Score
Solvency Due Diligence
Immutep Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Immutep Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IMM Price Targets Summary
Immutep Ltd
According to Wall Street analysts, the average 1-year price target for
IMM
is 1.145 AUD
with a low forecast of 0.465 AUD and a high forecast of 2.205 AUD.
Dividends
Current shareholder yield for
IMM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IMM
stock under the Base Case scenario is
1.837
AUD.
Compared to the current market price of 0.265 AUD,
Immutep Ltd
is
Undervalued by 86%.